Rheumatology
Conference Coverage
NSAIDs for spondyloarthritis may affect time to conception
“If a woman is requiring regular NSAIDs for symptom control, the results of this study might encourage me to consider a biologic agent sooner to...
Conference Coverage
Combination therapy shows mixed results for scleroderma-related lung disease
A study of mycophenolate mofetil alone and in combination with pirfenidone for scleroderma-related interstitial lung disease showed mixed results...
Conference Coverage
Lower hydroxychloroquine dose for lupus tied to hospitalizations for flares
Longer-term HCQ-induced retinopathy risk must be balanced with shorter-term risk for hospitalization for an SLE flare from a lower dose,...
Conference Coverage
Remibrutinib safe for Sjögren’s in phase 2
Results show the Bruton tyrosine kinase inhibitor has potential to become the first effective oral disease-modifying therapy for Sjögren syndrome...
Conference Coverage
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory...
Conference Coverage
Rituximab ‘a reasonable alternative to cyclophosphamide’ to improve ILD-CTD
A clinical trial found that rituximab and cyclophosphamide had similar outcomes for interstitial lung disease associated with connective tissue...
Conference Coverage
Clinical signs differ between children and adults with vasculitis
Many pediatric rheumatologists believe kids with vasculitis are like small adults and should be treated similarly, but Dr. Jessica Bloom said the...
Guidelines
First recommendations for cancer screening in myositis issued
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
Guidelines
ACR introduces guideline for integrative interventions in RA
The range of recommended interventions highlighted the multidisciplinary nature of rheumatoid arthritis disease management.
Feature
In rheumatoid arthritis, reducing inflammation reduces dementia risk
Compared with conventional synthetic disease-modifying antirheumatic drugs, biologic/targeted synthetic DMARDS lower dementia risk.
From the Journals
Therapeutic drug monitoring pays off for arthritis patients
Patients who reduced their dosage of TNF-alpha inhibitor had less treatment failure and similar risk of adverse events, compared with standard...